H.Res. 1285 · 119th Congress (2025–2027)
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.Res. 1285’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Diana DeGette (D-CO-1)
- Cosponsors
54 cosponsors
12 original · 42 later
54 D
- Rep. Becca Balint (D-VT)· Original · May 14, 2026
- Rep. Wesley Bell (D-MO-1)· Original · May 14, 2026
- Rep. Katherine M. Clark (D-MA-5)· Original · May 14, 2026
- Rep. Maxine Dexter (D-OR-3)· Original · May 14, 2026
- Rep. Jesús G. "Chuy" García (D-IL-4)· Original · May 14, 2026
- Rep. Seth Moulton (D-MA-6)· Original · May 14, 2026
- Rep. Jennifer L. McClellan (D-VA-4)· Original · May 14, 2026
- Del. Eleanor Holmes Norton (D-DC)· Original · May 14, 2026
- Rep. Ayanna Pressley (D-MA-7)· Original · May 14, 2026
- Rep. Brittany Pettersen (D-CO-7)· Original · May 14, 2026
- Rep. Paul Tonko (D-NY-20)· Original · May 14, 2026
- Rep. Nydia M. Velázquez (D-NY-7)· Original · May 14, 2026
- Rep. Kathy Castor (D-FL-14)· Later · May 21, 2026
- Rep. André Carson (D-IN-7)· Later · May 21, 2026
- Rep. Judy Chu (D-CA-28)· Later · May 21, 2026
- Rep. Salud O. Carbajal (D-CA-24)· Later · May 21, 2026
- Rep. Jasmine Crockett (D-TX-30)· Later · May 21, 2026
- Rep. Christopher R. Deluzio (D-PA-17)· Later · May 21, 2026
- Rep. Suzan K. DelBene (D-WA-1)· Later · May 21, 2026
- Rep. Sharice Davids (D-KS-3)· Later · May 21, 2026
- Rep. Bill Foster (D-IL-11)· Later · May 21, 2026
- Rep. Lois Frankel (D-FL-22)· Later · May 21, 2026
- Rep. John Garamendi (D-CA-8)· Later · May 21, 2026
- Rep. Jared Huffman (D-CA-2)· Later · May 21, 2026
- Rep. Jonathan L. Jackson (D-IL-1)· Later · May 21, 2026
- Rep. Julie Johnson (D-TX-32)· Later · May 21, 2026
- Rep. Timothy M. Kennedy (D-NY-26)· Later · May 21, 2026
- Rep. Summer L. Lee (D-PA-12)· Later · May 21, 2026
- Rep. Gregory W. Meeks (D-NY-5)· Later · May 21, 2026
- Rep. Gwen Moore (D-WI-4)· Later · May 21, 2026
- Rep. Dave Min (D-CA-47)· Later · May 21, 2026
- Rep. Johnny Olszewski, Jr. (D-MD-2)· Later · May 21, 2026
- Rep. Chellie Pingree (D-ME-1)· Later · May 21, 2026
- Rep. Deborah K. Ross (D-NC-2)· Later · May 21, 2026
- Rep. Janice D. Schakowsky (D-IL-9)· Later · May 21, 2026
- Rep. Greg Stanton (D-AZ-4)· Later · May 21, 2026
- Rep. Andrea Salinas (D-OR-6)· Later · May 21, 2026
- Rep. Lateefah Simon (D-CA-12)· Later · May 21, 2026
- Rep. Lori Trahan (D-MA-3)· Later · May 21, 2026
- Rep. Ritchie Torres (D-NY-15)· Later · May 21, 2026
- Rep. Maxine Waters (D-CA-43)· Later · May 21, 2026
- Rep. Frederica S. Wilson (D-FL-24)· Later · May 21, 2026
- Rep. Steve Cohen (D-TN-9)· Later · Jun 23, 2026
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)· Later · Jun 23, 2026
- Rep. Mark DeSaulnier (D-CA-10)· Later · Jun 23, 2026
- Rep. Josh Gottheimer (D-NJ-5)· Later · Jun 23, 2026
- Rep. Joseph D. Morelle (D-NY-25)· Later · Jun 23, 2026
- Rep. Sarah McBride (D-DE)· Later · Jun 23, 2026
- Rep. Emilia Strong Sykes (D-OH-13)· Later · Jun 23, 2026
- Rep. Julia Brownley (D-CA-26)· Later · Jun 24, 2026
- Rep. April McClain Delaney (D-MD-6)· Later · Jul 15, 2026
- Rep. Nellie Pou (D-NJ-9)· Later · Aug 20, 2026
- Rep. Lizzie Fletcher (D-TX-7)· Later · Sep 1, 2026
- Rep. Yvette D. Clarke (D-NY-9)· Later · Oct 1, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Submitted in House
Document: Introduced in House
Sources
- Congress.gov action
- House floor actions
- Latest
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (1)
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Display title, Official title · Introduced in House